Heterogeneous nuclear ribonucleoprotein A1 pseudogene 32 (HNRNPA1P32)

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 32 (HNRNPA1P32) is classified as a pseudogene and not a protein-coding gene or a canonical molecular target. Pseudogenes are gene copies that have lost their protein-coding ability due to accumulated mutations, deletions, or truncations, and therefore do not produce functional proteins[4]. While the parent gene HNRNPA1 encodes an RNA-binding protein involved in numerous cellular processes (such as RNA splicing and transport)[6], the pseudogene variants like HNRNPA1P32 generally lack biological function and are not considered therapeutic targets. Most information regarding hnRNPA1 pertains to the functional gene, not its pseudogenes. There is no evidence that HNRNPA1P32 has a characterized biological role or relevance as a drug target. Context: - HNRNPA1P32 fits the nomenclature for a pseudogene of the functional HNRNPA1 gene. - Pseudogenes may sometimes act as RNA molecules involved in regulation (e.g., as competitive endogenous RNAs or RNA sponges in certain cases described for other pseudogenes[4]), but there is no specific literature attributing such a role to HNRNPA1P32. - No known drugs, mechanisms of action, biomarkers, or disease associations are linked to HNRNPA1P32. - This entry is likely a database artifact or gene annotation without direct therapeutic or biological relevance. - The functional and drug discovery literature focuses on the HNRNPA1 protein, not its pseudogenes[1][2][3][5][6][8]. If information on the functional target is required, please refer to "Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1)" instead.